Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-23-001501
Filing Date
2023-02-17
Accepted
2023-02-17 17:09:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 cohenco-aeha021523a1.htm SC 13G/A 181833
  Complete submission text file 0001172661-23-001501.txt   183595
Mailing Address 3 COLUMBUS CIRCLE SUITE 2400 NEW YORK NY 10019
Business Address C/O MOURANT GOVERNANCE SVCS (CAYMAN) LTD 94 SOLARIS AVENUE, BOX 1348 GRAND CAYMAN E9 KY1-1108 215-701-9675
Vellar Opportunities Fund Master, Ltd. (Filed by) CIK: 0001812301 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc. (Subject) CIK: 0001869974 (see all company filings)

EIN.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92863 | Film No.: 23643886
SIC: 2834 Pharmaceutical Preparations